Emerging Company Profile
Immune-Onc building broad pipeline of myeloid checkpoint inhibitors
Emerging Company Profile: Founded by Guo-Liang Yu and Charlene Liao, the cancer play’s lead is a first-in-class ILT3 inhibitor
Founded by serial entrepreneur Guo-Liang Yu and Genentech alum Charlene Liao, Immune-Onc is building a pipeline of myeloid-targeting cancer agents, starting with a first-in-class ILT3 inhibitor.
Feb 26, 2021 | 11:12 PM GMT
Launched in 2016, Immune-Onc is part of a growing class of immuno-oncology companies